TX Health System Launches Population Health, Genomics Initiative
Texas-based Memorial Hermann Health System and Helix have announced a new collaboration to launch a population genomics program in an effort to personalize patient care.
Source: Thinkstock
By - Houston, Texas-based Memorial Hermann Health System has announced a partnership with population genomics and viral surveillance company, Helix to launch an initiative focused on enhancing population health by utilizing genomic data.
The initiative will include data from an anticipated 100,000 patients, making it one of the largest population health programs in Texas to date. Memorial Hermann will recruit participants from within its network, at no cost to the patients. Participants will be asked to mail in a one-time saliva sample, which will then be analyzed using Helix’s whole exome sequencing platform. The resulting data will be translated into useable insights that can identify a patient’s risk for certain conditions, such as cardiovascular disease.
By identifying patient risk and sharing all data findings with patients, the collaboration aims to enable providers and patients can make proactive decisions on care, with a potential to delay, reduce, or even prevent detrimental health effects. By personalizing care in this way, Memorial Hermann and Helix hope to improve health outcomes for Houston’s communities at large.
"Unlocking the insights of DNA will allow our affiliated providers to create precise, personalized plans for our patients and protect more people from preventable disease," said David Callender, MD, President and CEO of Memorial Hermann, in the press release. "Our mission is to improve the health of all those we serve. We know that population genomics is an increasingly important resource helpful for providing patients with the best possible care and ultimately improving their long-term health."
Using Helix’s genomics platform also allows Memorial Hermann to run further tests in the future without the need to collect additional genetic samples, streamlining the analytics process as new genomic testing is developed over time. Participation is optional, and patients have complete control over how the information gathered for the initiative is used and shared.
"By identifying risks earlier, Memorial Hermann is innovating care delivery to go beyond standard medical practice. Working together with their providers, we hope to inspire patients – whether through medications, diet and exercise, behavioral changes or other medical options – to take greater control of their health," said Callender.
This partnership coincides with the launch of other precision health initiatives across the country.
Earlier this week, the Ohio State University (OSU) Wexner Medical Center and Siemens Healthineers struck a partnership focused on advancing personalized medicine and improving access to high quality, cost-effective healthcare by implementing cutting-edge imaging and treatment technologies.
Under the collaboration, OSU and Siemens Healthineers hope to create a “living lab” to speed breakthroughs in personalized medicine and healthcare delivery. Current projects being undertaken include integrating AI-driven advanced imaging and cutting-edge radiation oncology modalities at OSU’s newest outpatient center, developing advanced imaging methods to Improves access to care for obese and claustrophobic patients, and expanding next-generation vascular robotics capabilities with the long-term goal of providing better access to advanced treatments across Ohio.
